Xenetic Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Xenetic Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q3 2024.
  • Xenetic Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $40.6M, a 3.57% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $40.6M +$1.4M +3.57% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $40.4M +$1.4M +3.59% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $40.1M +$1.4M +3.62% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $39.7M +$1.13M +2.93% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $39.2M +$6.4M +19.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $39M +$6.4M +19.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $38.7M +$6.9M +21.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $38.6M +$7.19M +22.9% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $32.8M +$2.3M +7.54% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $32.6M +$2.4M +7.95% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $31.8M +$1.9M +6.36% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $31.4M +$1.73M +5.84% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $30.5M +$4M +15.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $30.2M +$3.9M +14.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $29.9M +$3.8M +14.6% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $29.6M +$3.77M +14.6% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $26.5M +$300K +1.15% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $26.3M +$2.2M +9.13% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $26.1M +$2.3M +9.66% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $25.9M +$2.39M +10.2% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $26.2M +$2.2M +9.17% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $24.1M +$500K +2.12% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $23.8M +$600K +2.59% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $23.5M +$720K +3.16% Dec 31, 2018 10-K 2020-03-26
Q3 2018 $24M $0 0% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $23.6M +$400K +1.72% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $23.2M -$1.2M -4.92% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $22.8M +$1.26M +5.87% Dec 31, 2017 10-K 2019-03-29
Q3 2017 $24M +$7.5M +45.5% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $23.2M +$6.7M +40.6% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $24.4M +$7.9M +47.9% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $21.5M +$6.18M +40.3% Dec 31, 2016 10-K 2018-03-30
Q3 2016 $16.5M -$700K -4.07% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $16.5M +$1.4M +9.27% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $16.5M +$1.9M +13% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $15.3M +$1.55M +11.3% Dec 31, 2015 10-K 2017-03-31
Q3 2015 $17.2M +$3.7M +27.4% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $15.1M +$3.1M +25.8% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $14.6M +$4.6M +46% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 $13.8M +$4.25M +44.7% Dec 31, 2014 10-K 2016-03-30
Q3 2014 $13.5M Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $12M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $10M Mar 31, 2014 10-Q 2014-05-20
Q4 2013 $9.52M +$374K +4.09% Dec 31, 2013 10-K/A 2015-07-20
Q4 2012 $9.15M Dec 31, 2012 10-K/A 2015-07-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.